ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OFIX vs CLPT // NET PROFIT MARGIN

Orthofix Medical Inc. (NASDAQ) VS. ClearPoint Neuro Inc. (NASDAQ) • 15-METRIC TALLY: OFIX 8 — CLPT 2
▲ NET PROFIT MARGIN LEADER: OFIX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OFIX VS. CLPT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OFIX CLPT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 68.80% 61.40% +7.40 OFIX /gross-margins <GO>
Return on Invested Capital (ROIC) -12.20% -35.00% +22.80 OFIX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 7.99% -7.13% +15.12 OFIX /fcf-yield <GO>
Operating Margin -9.90% -60.00% +50.10 OFIX /operating-margins <GO>
Net Profit Margin ACTIVE -11.20% -60.00% +48.80 OFIX /net-margins <GO>
Revenue Growth (YoY) 2.90% 17.80% -14.90 CLPT /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.02 0.20 +0.82 OFIX /balance-sheet <GO>
Piotroski F-Score Quality 7/9 4/9 +3.00 OFIX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.8 48.9 -4.10 CLPT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $369.4M $342.0M $27.4M OFIX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OFIX REV CLPT REV OFIX GROSS % CLPT GROSS % OFIX FCF CLPT FCF
FY 2025 $822.3M $37.0M 68.8% 61.4% $33.3M -$24.4M
FY 2024 $799.5M $31.4M 68.3% 60.9% $25.8M -$9.2M
FY 2023 $746.6M $24.0M — — -$45.8M -$13.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OFIX // BETA —
CLPT // BETA —